Dechra Pharmaceuticals Share Price (DPH)

1,011.50 -14.50 (-1.41%) delayed: 9:02PM GMT
Bid price 995.00 Open price 1,020.00
Ask price 1,028.00 Prev close 1,026.00
High price 1,028.00 Spread 3.21%
Low price 1,007.00 Volume 80,406

Register now for FREE live Dechra Pharmaceuticals share prices, Dechra Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Dechra Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Dechra Pharmaceuticals (DPH) and other London Stock Exchange equities.

Dechra Pharmaceuticals Share Price Chart

Advanced Charts >>

Register now for FREE Dechra Pharmaceuticals share price charts

Dechra Pharmaceuticals Share Price Information

Name Dechra Pharmaceuticals Epic DPH
Sector Pharmaceuticals & Biotechnology ISIN GB0009633180
Activites Dechra Pharmaceuticals plc is an international veterinary pharmaceutical business. Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. Index FTSE 250

Dechra Pharmaceuticals Key Numbers

Latest Share Price (p) 1,011.50 Net Gearing (%) 17.70
Market Capitalisation (£m) 903.43 Gross Gearing (%) 33.42
Shares in issue (m) 87.97 Debt Ratio 21.58
P/E Ratio 46.39 Debt-to-Equity Ratio 0.55
Total dividends per share (p) 16.94 Assets / Equity Ratio 1.50
Dividend Yield (%) 1.65 Price to book value 4.65
Dividend cover (x) 1.25 ROCE (%) 10.41
Earning per share (p) 22.14 EPS Growth (%) -67.23
52 week high / low 1,110.00 / 852.50 DPS Growth (%) 10.00

Dechra Pharmaceuticals Director Deals

Dec.Date Type Director Pos No. of Shares
09/09/2015 EXR Anne-Françoise Nesmes FD 38,859
09/09/2015 SEXR Anne-Françoise Nesmes FD 18,319
12/09/2014 EXR Ian Page CEO 92,811
12/09/2014 SEXR Ian Page CEO 43,753
03/03/2014 EXR Ian Page CEO 78,656

More Dechra Pharmaceuticals Director Deals >>

Dechra Pharmaceuticals Company News

15:44 08/02/2016

Additional Listing

/* */ RNS Number : 4223O Dechra Pharmaceuticals PLC 08 February 2016         8 February 2016   Dechra ® Pharmaceuticals PLC (Dechra or the Company)      Additional Listing  ...

07:00 01/02/2016

Total Voting Rights

/* */ RNS Number : 5159N Dechra Pharmaceuticals PLC 01 February 2016         1 February 2016   Dechra ® Pharmaceuticals PLC (Dechra or the Company)      In conformity with DTR 5.6.1R, the...

08:10 14/01/2016

Dechra revenues up in strong first half

Dechra Pharmaceuticals reports strang first half trading with revenue growth including Genera, of approximately 15% at constant currencies and 10% at actual exchange rates. Excluding Genera, which was acquired in October, revenue growth was 11% at constant currencies and 7% at actual rate....

More Dechra Pharmaceuticals Company News >>

Register now for FREE Dechra Pharmaceuticals company news

Dechra Pharmaceuticals Share Price Discussions

more than 1 year ago

A really dreary share (DPH)

A really dreary share! Dechra Pharmaceuticals manufactures and distributes vetinary products and equiptment.Has a few own brands:- Equipalazone,Vetoryl and Felimazole -anyone used them? My stockbroker molested me so much over this company that I finally bought at 130p,(Feb 04); now at 182.5p...

Register now for FREE Dechra Pharmaceuticals share price discussions